FASN-IN-3 NEW
| Price | $41 | $41 | $100 | $100 | $161 | $161 |
| Package | 1mg | 1mg | 5mg | 5mg | 10mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-20 |
Product Details
| Product Name: FASN-IN-3 | CAS No.: 2097262-60-5 |
| Purity: 98.22% | Supply Ability: 10g |
| Release date: 2026/04/20 |
Product Introduction
Bioactivity
| Name | FASN-IN-3 |
| Description | FASN-IN-3 is an inhibitor of fatty acid synthase (FASN). |
| In vitro | For monocytes, FASN-IN-3 treatment reduces the level of IL-1 beta resulting from LTA stimulation whereas there is only a slight reduction after LPS stimulation.Human PBMC and monocytes in cell cultures are stimulated with lipopolysaccharide (LPS), a Toll 4 receptor agonist, or lipoteichoic acid (LTA), a Toll 2 receptor agonist. Stimulation with either LPS or LTA plus DMSO, the solvent for FASN-IN-3 , results in secretion of IL-1 beta. FASN inhibitor 1 treatment of PBMC, which is a mixed population of mononuclear cells including both lymphocytes and monocytes, reduces the level of IL-1 beta resulting from either LPS or LTA stimulation. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.2 mM), Sonication is recommended. DMSO : 33.33 mg/mL (86.69 mM), Sonication and heating to 80℃ are recommended. |
| Keywords | Inhibitor | inhibit | FattyAcidSynthase | Fatty Acid Synthase (FASN) | Fatty Acid Synthase | FASN-IN-3 | FASNIN3 | FASN IN 3 | FASN |
| Inhibitors Related | 2-Octanone | Betulin | Malic enzyme inhibitor ME1 | Maltitol | Coenzyme A | Pyrazinamide | A-769662 | trans-Chalcone | Orlistat | L-Carnitine | Pseudoprotodioscin | Lycorine |
| Related Compound Libraries | Bioactive Compound Library | ReFRAME Related Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Inhibitor Library | NO PAINS Compound Library | Lipid Metabolism Compound Library | Metabolism Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $55.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $1980.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
| $1.00 |
VIP8Y
|
.GZ HONESTCHEM CO.,LTD
|
2026-07-20 | |
| $41.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-04-22 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY